HARP
Income statement / Annual
Last year (2022), Harpoon Therapeutics, Inc.'s total revenue was $31.92 M,
an increase of 34.92% from the previous year.
In 2022, Harpoon Therapeutics, Inc.'s net income was -$67.14 M.
See Harpoon Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$31.92 M
|
$23.65 M
|
$17.44 M
|
$5.78 M
|
$4.75 M
|
$708,000.00
|
$0.00
|
| Cost of Revenue |
$3.10 M |
$2.65 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$28.82 M |
$21.01 M |
$17.44 M |
$5.78 M |
$4.75 M |
$708,000.00 |
$0.00 |
| Gross Profit Ratio |
0.9 |
0.89 |
1 |
1 |
1 |
1 |
0 |
| Research and Development
Expenses |
$81.39 M
|
$72.12 M
|
$52.57 M
|
$41.59 M
|
$26.37 M
|
$13.62 M
|
$7.78 M
|
| General & Administrative
Expenses |
$18.85 M
|
$18.33 M
|
$16.21 M
|
$22.39 M
|
$6.11 M
|
$3.61 M
|
$3.37 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$18.85 M
|
$18.33 M
|
$16.21 M
|
$22.39 M
|
$6.11 M
|
$3.61 M
|
$3.37 M
|
| Other Expenses |
-$182,000.00 |
-$210,000.00 |
-$26,000.00 |
-$42,000.00 |
-$37,000.00 |
-$17,000.00 |
-$4,000.00 |
| Operating Expenses |
$100.24 M |
$90.45 M |
$68.78 M |
$63.98 M |
$32.47 M |
$17.24 M |
$11.15 M |
| Cost And Expenses |
$100.24 M |
$90.45 M |
$68.78 M |
$63.98 M |
$32.47 M |
$17.24 M |
$11.15 M |
| Interest Income |
$776,000.00 |
$240,000.00 |
$1.45 M |
$2.68 M |
$395,000.00 |
$0.00 |
$6,000.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$285,000.00 |
$261,000.00 |
| Depreciation &
Amortization |
$2.36 M
|
$102.10 M
|
$2.08 M
|
$900,000.00
|
$644,000.00
|
$366,000.00
|
$198,000.00
|
| EBITDA |
-$65.97 M
|
-$14.65 M
|
-$49.25 M
|
-$58.21 M
|
-$27.37 M
|
-$16.16 M
|
-$10.95 M
|
| EBITDA Ratio |
-2.14 |
-0.62 |
-2.94 |
-10.08 |
-5.76 |
-22.85 |
0 |
| Operating Income Ratio
|
-2.14
|
-4.94
|
-2.94
|
-10.08
|
-5.84
|
-23.34
|
0
|
| Total Other
Income/Expenses Net |
$594,000.00
|
$30,000.00
|
$1.42 M
|
$2.63 M
|
$358,000.00
|
-$302,000.00
|
-$259,000.00
|
| Income Before Tax |
-$67.73 M |
-$116.72 M |
-$49.91 M |
-$55.57 M |
-$27.37 M |
-$16.83 M |
-$11.41 M |
| Income Before Tax Ratio
|
-2.12
|
-4.93
|
-2.86
|
-9.62
|
-5.76
|
-23.77
|
0
|
| Income Tax Expense |
-$594,000.00 |
$49.71 M |
-$3.53 M |
-$3.58 M |
$358,000.00 |
$268,000.00 |
$257,000.00 |
| Net Income |
-$67.14 M |
-$166.44 M |
-$46.38 M |
-$52.00 M |
-$27.37 M |
-$16.83 M |
-$11.41 M |
| Net Income Ratio |
-2.1 |
-7.04 |
-2.66 |
-9 |
-5.76 |
-23.77 |
0 |
| EPS |
-20.24 |
-51.57 |
-18.52 |
-23.91 |
-11.45 |
-17.81 |
-1.21 |
| EPS Diluted |
-20.24 |
-51.57 |
-18.52 |
-23.91 |
-11.45 |
-17.81 |
-1.21 |
| Weighted Average Shares
Out |
$3.32 M
|
$3.23 M
|
$2.50 M
|
$2.17 M
|
$2.39 M
|
$944,807.00
|
$9.45 M
|
| Weighted Average Shares
Out Diluted |
$3.32 M
|
$3.23 M
|
$2.50 M
|
$2.17 M
|
$2.39 M
|
$944,807.00
|
$9.45 M
|
| Link |
|
|
|
|
|
|
|
